low grade glioma

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Low Grade Glioma, Malignant Brain Glioma, Malignant Brain Tumor Trial in Atlanta (procedure, drug, other)

Not yet recruiting
  • Low Grade Glioma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Nov 7, 2023

Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

Not yet recruiting
  • Low Grade Glioma
  • model-guided optimization of treatment plan
  • standard treatment plan, no optimization
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Jul 19, 2023

Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI scanner
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

Ovarian Aging in Low Grade Glioma Treated With Temozolomide

Terminated
  • Low Grade Glioma
    • San Francisco, California
      UCSF Center for Reproductive Health
    Jul 6, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +113 more
    Jun 28, 2022

    Seizure Control asNew Metric in Assessing Efficacy of Tumor

    Active, not recruiting
    • Brain Neoplasm
    • +2 more
    • Survey Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 21, 2022

    Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

    Terminated
    • Low Grade Glioma
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Nov 3, 2021

    Glioblastoma, Low Grade Glioma, Malignant Glioma Trial in Houston (Mind-Body Intervention Procedure, Quality-of-Life Assessment,

    Completed
    • Glioblastoma
    • +5 more
    • Mind-Body Intervention Procedure
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2021

    Brain Tumor, Low Grade Glioma, Astrocytoma Trial in Boston (Proton radiotherapy)

    Active, not recruiting
    • Brain Tumor
    • +4 more
    • Proton radiotherapy
    • Boston, Massachusetts
    • +1 more
    Sep 30, 2021

    Low Grade Glioma Trial in Pittsburgh (Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC)

    Recruiting
    • Low Grade Glioma
    • Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC
    • Pittsburgh, Pennsylvania
      Children's Hospital of Pittsburgh of UPMC
    Aug 3, 2021

    Low Grade Glioma Trial in Worldwide (Vinblastine, Bevacizumab)

    Recruiting
    • Low Grade Glioma
    • Los Angeles, California
    • +20 more
    Mar 11, 2020

    (11C)dLop as a Marker of P-Glycoprotein Function in Gliomas

    Terminated
    • Low Grade Glioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jul 3, 2018

      Rotating Frame Relaxation and Diffusion Weighted Imaging of

      Completed
      • Low Grade Glioma
      • Malignant Glioma
        • Turku, Finland
          Turku University Hospital
        Jun 13, 2018

        Low Grade Glioma Trial in United States (Carboplatin, Vincristine)

        Unknown status
        • Low Grade Glioma
        • Phoenix, Arizona
        • +9 more
        Mar 23, 2018

        ROCOCO - Low Grade Glioma - Planning Study

        Completed
        • Low Grade Glioma
          • Heidelberg, Germany
          • +3 more
          Mar 27, 2017